RT Journal Article
SR Electronic
T1 Advances in pulmonary and pleural malignant disorders
JF Clinical Medicine
JO Clin Med
FD Royal College of Physicians
SP 234
OP 236
DO 10.7861/clinmedicine.19-3-234
VO 19
IS 3
A1 Jack A Kastelik
A1 Angshu Bhowmik
A1 John Park
YR 2019
UL http://www.rcpjournals.org/content/19/3/234.abstract
AB Lung and pleural malignancies remain common in the UK with poor survival rates due, at least in part, to late stage diagnosis. Diagnostic pathways aim to reduce the time taken for patients to reach a diagnosis and treatment, with the use of positron emission tomography and endobronchial ultrasound to provide staging information alongside diagnostics. Advances in molecular phenotyping of tumours and the development of treatments to target these have provided new therapeutic options which can be individualised to patients. In the UK, screening for lung cancer remains in its infancy, but provides a promising possibility for capturing curative disease. We provide an overview of the diagnostic process, therapeutic options and potential future screening programmes in pleural and pulmonary malignancies.